|
ZNF121 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.90409999954045E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.34910000000266E-05 |
| Normal-vs-Stage2 |
3.51769999999973E-05 |
| Normal-vs-Stage3 |
7.68499999970196E-07 |
| Normal-vs-Stage4 |
3.43099999999819E-06 |
| Stage1-vs-Stage2 |
2.346400E-01 |
| Stage1-vs-Stage3 |
2.148800E-01 |
| Stage1-vs-Stage4 |
1.816820E-01 |
| Stage2-vs-Stage3 |
7.694800E-01 |
| Stage2-vs-Stage4 |
9.067600E-01 |
| Stage3-vs-Stage4 |
8.579400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.24810000004627E-06 |
| Normal-vs-AfricanAmerican |
2.115800E-01 |
| Normal-vs-Asian |
8.30940000000613E-05 |
| Caucasian-vs-AfricanAmerican |
8.786200E-02 |
| Caucasian-vs-Asian |
6.206200E-01 |
| AfricanAmerican-vs-Asian |
9.416300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57280000023796E-07 |
| Normal-vs-Female |
1.73821999999157E-05 |
| Male-vs-Female |
2.141600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.635500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.67880000404119E-08 |
| Normal-vs-Age(61-80Yrs) |
1.610000E-04 |
| Normal-vs-Age(81-100Yrs) |
6.638500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.004500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.399400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.966800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.243000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.617800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.737200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.736000E-02 |
| Classical-VS-Follicular |
1.046300E-02 |
| Classical-VS-Other |
1.333200E-01 |
| Classical-VS-Normal |
9.63379999999736E-05 |
| Tall-VS-Follicular |
8.244600E-01 |
| Tall-VS-Other |
5.036800E-01 |
| Tall-VS-Normal |
5.58119999999329E-05 |
| Follicular-VS-Other |
6.811600E-01 |
| Follicular-VS-Normal |
1.6442000000394E-06 |
| Other-VS-Normal |
3.259200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.20459999997102E-06 |
| Normal-vs-N1 |
7.53620000000232E-05 |
| N0-vs-N1 |
8.233400E-01 |
|
|
